Berkshire Hathaway’s run to record territory has leaned on more than one crutch. Investors hunting for shelter from a market rattled by falling AI stocks and rising oil prices have pushed the shares higher, but that rotation alone won’t validate the valuation. The conglomerate’s own operating momentum — and what it does with roughly $360 billion in cash — will face a genuine audit when quarterly results land on November 7.
The stock’s most recent session told the story in miniature. Class B shares climbed 1.7% as capital fled AI-linked names amid uncertainty over how the Iran war might disrupt energy flows, according to media reports. That gain followed a record intraday high the prior day, though the shares ultimately closed lower — a reminder that a trading-day peak says little on its own. Reports at the time pointed to Berkshire’s defensive appeal and to investors gradually moving past Warren Buffett’s departure, with Greg Abel’s leadership and recent deals drawing more attention. No fresh company announcement drove that session’s move.
Two Threads That Shouldn’t Be Tangled
There’s a distinction investors ought to keep sharp: demand for Berkshire as a safe harbor is a separate matter from Berkshire’s own decisions about where to put its capital. The day’s relative strength wasn’t a response to any single acquisition.
Context on the capital-allocation side comes from a deal struck just over a week ago. Berkshire agreed to subscribe to 10 million newly issued Bending Spoons shares at $33 apiece, a private placement worth $330 million. Bending Spoons disclosed the agreement in a corporate release and a regulatory filing — an agreed investment, not a confirmed closing. According to the company, the arrangement followed Berkshire’s $600 million investment in its July IPO, and the additional stake is meant to lift Berkshire’s holding to 4%.
The Operating Record Behind the Rally
None of that, however, explains the climb by itself. The numbers underneath it do carry weight. In the second quarter of 2026, Berkshire’s operating profit rose 16% year over year, and net earnings reached $25.67 billion. The advance, then, reflects genuine business improvement rather than a pure shift in investor taste.
Should investors sell immediately? Or is it worth buying Berkshire Hathaway?
Insurance delivered solid underwriting results, with no major catastrophe losses in the quarter. Manufacturing, services and retail all posted revenue growth, helped along by the OxyChem acquisition. The picture isn’t uniformly bright. BNSF trailed Union Pacific on profitability, while Berkshire Hathaway Energy contended with wildfire litigation and regulatory obstacles. Come the next report, the question isn’t just whether the group grew — it’s whether the laggards are making headway and how underwriting is trending.
Cash as an Earnings Engine
Berkshire’s cash mountain isn’t merely dry powder for future deals; it generates interest income that flows straight into results. That stream complements the cash thrown off by insurance, utilities and rail, and it helps explain Berkshire’s appeal in a market where investors are leaning toward quality and lower risk. It doesn’t make the performance of individual operating units any less important.
UBS, for its part, lifted its price target on the A-shares from $906,000 to $942,000. That’s an analyst’s view, not a promise of future gains — and it raises the question of how much of Berkshire’s earnings strength is already baked into the price.
What the November 7 Report Must Settle
A broad rotation can favor Berkshire without any commensurate change in its business outlook, and it can reverse just as quickly. That makes the upcoming quarterly release the real proving ground for the record run. Investors will get to judge whether operating growth and interest income can carry the heightened expectations — and, most tellingly, whether the strength is spread across multiple business lines or still concentrated in a handful of profit sources.
Ad
Berkshire Hathaway Stock: Buy or Sell?! New Berkshire Hathaway Analysis from October 23 delivers the answer:
The latest Berkshire Hathaway figures speak for themselves: Urgent action needed for Berkshire Hathaway investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from October 23.
Berkshire Hathaway: Buy or sell? Read more here...
